[Corrigendum] Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer

• Authors:
  • Tomoka Maehana
  • Ryuji Kawaguchi
  • Kyohei Nishikawa
  • Naoki Kawahara
  • Yuki Yamada
  • Fuminori Kimura

• View Affiliations

  
  Affiliations: Department of Obstetrics and Gynecology, Nara Medical University, Shijo, Kashihara, Nara 634‑8522, Japan
• Published online on: March 17, 2025     https://doi.org/10.3892/ol.2025.14978
• Article Number: 232

• Copyright : © Maehana et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article